Darbepoetin alfa
Janessa Smith, Pharm.D., BCPS
,
Paul A. Pham, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Anemia
due to chronic kidney disease (CKD) in patients on dialysis and those not on dialysis
Anemia
due to myelosuppressive chemotherapy with a minimum of at least 2 months of planned therapy
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Anemia
-associated with HIV or ART in pts with low
erythropoietin
levels
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.